Form 4/A · Filed Jul 17, 2026, 11:12 PM UTC
ETON/Eton Pharmaceuticals, Inc.
Opaleye Management Inc. — 10pct_owner
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
2 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jul 14, 2026 | S | sell | 15,000 | $38 | $563,147 | 2,665,000 |
| Jul 14, 2026 | S | sell | 13,315 | $38 | $499,886 | 40,000 |
Source: SEC EDGAR raw filing ↗ · Accession 0001493152-26-033818